Subscribe 600$/product give away!
Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     


Inform Patients Of The Risks Associated With Argatroban Injection As Well As The Plan For Regular Monitoring During Administration Of The Drug. Specifically, Inform Patients To Report:

the use of any other products known to affect bleeding.
any medical history that may increase the risk for bleeding, including a history of severe hypertension; recent lumbar puncture or spinal anesthesia; major surgery, especially involving the brain, spinal cord, or eye; hematologic conditions associated with increased bleeding tendencies such as congenital or acquired bleeding disorders and gastrointestinal lesions such as ulcerations.
any bleeding signs or symptoms[see Warnings and Precautions (5.1)].
the occurrence of any signs or symptoms of allergic reactions (e.g., airway reactions, skin reactions and vasodilation reactions)[see Adverse Reactions (6.1)].
Distributed by
Sandoz Inc., Princeton, NJ 08540
Rev. April 2019

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: